Estradiol worsens the syndrome of ischemia-reperfusion injury in an experimental lung transplantation model

Lung

Volumn 189, Issue 3, 2011, Pages 251-255

  Santana Rodríguez, Norberto ^a,b   Clavo, Bernardino ^a   Llontop, Pedro ^a   López, Ana ^c   García Castellano, José Manuel ^a   Machín, Rubén P ^a   Ponce, Miguel A ^a,b   Fiuza, María D ^a   García Herrera, Ricardo ^a   Brito, Yanira ^a   Yordi, Nagib Atallah ^d   Chirino, Ricardo ^e  

^a HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^b Instituto Canario   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d Al Noor Hospital   (United Arab Emirates)

^e UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

Author keywords

Acute rejection; Antioxidants; Experimental lung transplantation; Ischemia reperfusion injury

Indexed keywords

DEFEROXAMINE; DEFEROXAMINE MESYLATE; ESTRADIOL; ESTROGEN; MELATONIN; PEROXIREDOXIN 5;

ACUTE GRAFT REJECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; EDEMA; EXPERIMENTAL MODEL; ISCHEMIA; LUNG TRANSPLANTATION; MALE; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; REPERFUSION; REPERFUSION INJURY; SINGLE DRUG DOSE;

ANIMALS; ANTIOXIDANTS; CHI-SQUARE DISTRIBUTION; DEFEROXAMINE; DISEASE MODELS, ANIMAL; ESTRADIOL; GRAFT REJECTION; GRAFT SURVIVAL; LUNG; LUNG INJURY; LUNG TRANSPLANTATION; MALE; MELATONIN; OXIDATIVE STRESS; PULMONARY EDEMA; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 79959890237     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-011-9287-2     Document Type: Article

References (23)

1. De Perrot M, Liu M, Waddell T, Keshavjee S (2003) Ischemia-reperfusion- induced lung injury. Am Resp J Crit Care Med 167:490-511
2. Carter YM, Davis RD (2006) Primary graft dysfunction in lung transplantation. Semin Respir Crit Care Med 27:501-507 (Pubitemid 44672553)
3. McCord JM (1985) Oxygen-derivated free radicals in postischemic tissue injury. N Engl J Med 312:159-163
4. Christofidou-Solomidou M, Muzykantov VR (2006) Antioxidant strategies in respiratory medicine. Treat Respir Med 5:47-78 (Pubitemid 43116813)
5. Bittner HB, Binner C, Dahlberg P, Mohr FW (2007) Reducing ischemia-reperfusion injury in clinical lung transplantation. Transplant Proc 39:489-492 (Pubitemid 46386208)
6. Knoop C, Estenne M (2006) Acute and chronic rejection after lung transplantation. Semin Respir Crit Care Med 27:521-533 (Pubitemid 44672555)
7. Marboe CC (2007) Pathology of lung transplantation. Semin Diagn Pathol 24:188-198
8. Santana Rodríguez N, Martín Barrasa JL, López García A, Rodríguez Suárez P, Ponce González M, Freixinet Gilart J (2004) Lung transplantation in rats: a viable experimental model. Arch Bronconeumol 40:438-442 (Pubitemid 39452426)
9. Stewart S, Fishbein MC, Snell GI, Berry GJ, Boehler A, Burke M (2007) Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 26:1229-1242 (Pubitemid 350256994)
10. Inci I, Inci D, Dutly A (2002) Melatonin attenuates post transplant lung ischemia-reperfusion injury. Ann Thorac Surg 73:220-225 (Pubitemid 34084566)
11. Demertzis S, Scherer M, Langer F (2000) Ascorbic acid for amelioration of reperfusion injury in a lung autotransplantation model in sheep. Ann Thorac Surg 70:1684-1689
12. Kuwaki K, Komatsu K, Sohma H, Abe T (2000) Improvement of ischemia-reperfusion injury by lazaroid U74389G in rat lung transplantation model. Scand Cardiovasc J 34:209-212
13. Fuller BJ, Lunec J, Healing G (1986) Reduction of susceptibility to lipid peroxidation by desferrioxamine in rabbit kidneys subjected to 24-hour cold ischemia and reperfusion. Transplantation 43:604-606
14. Gürdöl F, Genç S, Oner-Iyidogan Y, Süzme R (2001) Coadministration of melatonin and estradiol in rats: effects oxidant status. Horm Metab Res 33:608-611
15. Omar R, Nomikos I, Picorelli G (1989) Prevention of post ischemic lipid peroxidation and liver cell injury by iron chelation. Gut 30:510-514
16. Drugas G, Paidas C, Yahanda A (1991) Conjugated desferrioxamine attenuates hepatic microvascular injury following ischemia-reperfusion. Circ Shock 34:278-283
17. Loose-Mitchell D, Stancel G (2000) Estrogen and progestin. In: Hardman JG, Limbird LE, Gilman AG (eds) Goodman and Gilman's The Pharmacological Basis of Therapeutics. Mc-Graw Hill Professional, New York, pp 1613-1651
18. Huh K, Shin US, Choi JW (1994) Effect of sex hormones on lipid peroxidation in rat liver. Arch Pharm Res 17:109-114
19. Booth NH (1988) Hormones affecting reproduction. In: McDonald L (ed) Veterinary pharmacology and therapeutics, 6th edn. Iowa State Press, Ames, pp 603-628
20. Opgaard OS, Duckles SP, Krause DN (2002) Regional differences in the effect of estrogen on vascular tone in isolated rabbit arteries. Pharmacol Toxicol 91:77-82
21. Smolders RG, Van der Mooren MJ, Kenemans P (2002) 17 beta-Estradiol induces a rapid, endothelium-dependent, sex-specific vasodilatation in spontaneous constricted rat arterioles. Am J Obstet Gynecol 187:375-381 (Pubitemid 34925572)
22. Walsh LS, Ollendorff A, Mershon JL (2003) Estrogen increases inducible nitric oxide synthase gene expression. Am J Obstet Gynecol 188:1208-1210 (Pubitemid 36589104)
23. Tsang SY, Yao X, Chan HY (2003) Contribution of K + channels to relaxation induced by 17beta-estradiol but not by progesterone in isolated rat mesenteric artery rings. J Cardiovasc Pharmacol 41:4-13 (Pubitemid 36015050)